ECYT - Endocyte, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue707070
Cost of Revenue---
Gross Profit707070
Operating Expenses
Research Development25,866.84527,492.18526,309.475
Selling General and Administrative13,769.85317,298.13915,733.462
Non Recurring16,539.34716,539.34716,539.347
Total Operating Expenses---
Operating Income or Loss-56,106.045-44,720.324-41,972.937
Income from Continuing Operations
Total Other Income/Expenses Net1,041.895832.751703.188
Earnings Before Interest and Taxes-55,064.15-43,887.573-41,269.749
Interest Expense---
Income Before Tax-55,064.15-43,887.573-41,269.749
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-55,064.15-43,887.573-41,269.749
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-55,064.15-43,887.573-41,269.749
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-55,064.15-43,887.573-41,269.749